Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN‐France
American Journal of Hematology · 2026-03 · 101 (3) · 456-466
DOI: 10.1002/ajh.70192 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Hematology, online erschienen am 08.01.2026. Verfasst von François Therme und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Toulouse University Hospital, Toulouse, France. Hauptthemen laut MEDLINE: Venous Thrombosis, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: French National Society of Internal Medicine, Toulouse University Hospital, Amgen.
Abstract (Originalsprache)
Adult patients with immune thrombocytopenia (ITP) have an increased risk of venous thrombosis as compared to the general population. The management of ITP in the context of anticoagulation is challenging. We conducted an observational study in the prospective, multicenter, national CARMEN‐France registry. Adult patients with newly diagnosed ITP between June 2013 and May 2022 were selected. We assessed the cumulative incidence of venous thrombosis during follow‐up with death as a competing event, described these events, and assessed patient outcomes depending on management strategies, with a focus on thromboses that occurred during treatment with thrombopoietin receptor agonists (TPO‐RA). Among the 1303 patients selected for this study, 53 experienced venous thrombosis. The cumulative incidence of venous thrombosis was 2.6% (95% CI: 1.8–3.7) at 1 year and 8.6% (95% CI: 5.8–12.0) at 5 years. In patients exposed to TPO‐RA, the cumulative incidence was 9.3% (95% CI: 6.2–13.2) and 13.4% (95% CI: 8.6–19.2) at 1 and 5 years of exposure, respectively. Patients who experienced thrombosis were older, had more frequently a history of venous thrombosis and secondary ITP, a more severe ITP, and were more frequently treated with TPO‐RAs. Twenty (37.7%) of the 53 events were atypical, including five cerebral venous thromboses. Four patients died, and seven experienced major bleeding. The analysis of different managements of ITP after the thrombotic event suggested that the safest strategy was to promptly control ITP to enable early anticoagulation, including using TPO‐RAs. Long‐term anticoagulation therapy should be considered in patients treated with TPO‐RAs and persistent risk factors for thrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Toulouse University Hospital, Toulouse, France.
- Department of Internal Medicine, Bordeaux University Hospital, Bordeaux, France.
- Clinical Investigation Center 1436, Toulouse University Hospital, Toulouse, France.
- Department of Internal Medicine, Toulouse University Institute for Cancer (IUCT-Oncopole), Toulouse, France.
- Department of Hematology, Caen University Hospital, Caen, France.
- Department of Internal Medicine, Dijon University Hospital, Dijon, France.
ORCID-Profile: Thibault Comont, Matthieu Mahevas, Thomas Moulinet, Maryse Lapeyre-Mestre, Yoann Zadro, Marc Michel, Guillaume Moulis
Förderung
- French National Society of Internal Medicine
- Toulouse University Hospital
- Amgen
- Grifols
- Novartis
- Sanofi
Zitieren
APA
Therme, F., Viallard, J. F., Rueter, M., Comont, T., Cheze, S., Audia, S., Ebbo, M., Mahevas, M., Terriou, L., Reynaud, Q., Jeandel, P. Y., Moulinet, T., Gobert, D., Guilpain, P., Gourguechon, C., Robbins, A., Ruivard, M., Chabbert, L., Bonnotte, B., …, & Carmen‐France Investigators Group (2026). Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN‐France. American Journal of Hematology, 101(3), 456-466. https://doi.org/10.1002/ajh.70192
Vancouver
Therme F, Viallard JF, Rueter M, Comont T, Cheze S, Audia S, et al. Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN‐France. American Journal of Hematology. 2026;101(3):456-466. doi:10.1002/ajh.70192
BibTeX
@article{Therme2026,
author = {Therme, François and Viallard, Jean Francois and Rueter, Manuela and Comont, Thibault and Cheze, Stephane and Audia, Sylvain and Ebbo, Mikael and Mahevas, Matthieu and Terriou, Louis and Reynaud, Quitterie and Jeandel, Pierre-Yves and Moulinet, Thomas and Gobert, Delphine and Guilpain, Philippe and Gourguechon, Clément and Robbins, Ailsa and Ruivard, Marc and Chabbert, Laurie and Bonnotte, Bernard and Godeau, Bertrand and Lapeyre-Mestre, Maryse and Zadro, Yoann and Michel, Marc and Moulis, Guillaume and Carmen‐France Investigators Group, Carmen‐France Investigators Group},
title = {Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN‐France},
journal = {American Journal of Hematology},
year = {2026},
volume = {101},
number = {3},
pages = {456--466},
doi = {10.1002/ajh.70192}
}
EUVIMED